Integrated Biopharma
INBP · OTC
$0.18−$0.0024 (−1.32%)TodayMarket closed ·
No price history for this range.
Who owns INBP
Largest institutional holders, from their latest 13F filings
The 9 largest institutions hold 68.5% of INBP’s shares.
- CDDS 2.0, LLC41.0%
- E Gerald Kay UEO10.9%
- Kay (Heidi)5.2%
- Sheppard (Riva Kay)4.8%
- Next 5 largest institutions6.5%
- All other shareholders31.5%
| Holder | Shares | % of shares |
|---|---|---|
| CDDS 2.0, LLC | 12.73M | 41.00% |
| E Gerald Kay UEO | 3.39M | 10.93% |
| Kay (Heidi) | 1.63M | 5.23% |
| Sheppard (Riva Kay) | 1.51M | 4.85% |
| Kay (Christina) | 1.49M | 4.80% |
| Masi (Dina L) | 238.84K | 0.77% |
| Canarick (Robert) | 140.07K | 0.45% |
| Milmoe (William H) | 126.08K | 0.41% |
| Moloney Securities Asset Management, LLC | 20.00K | 0.06% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of INBP in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Friedman Eric J | Award | 50.00K | — |
| Milmoe William H. | Award | 50.00K | — |
| Canarick Robert | Award | 50.00K | — |
| DeSantis Damon | Award | 50.00K | — |
| Friedman Eric J | Award | 50.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4
- Days to cover
- 1.00
- % of shares outstanding
- 0.00%
- Average daily volume
- 42.80K
- Change since last report
- +0.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.